DAXOR CORP (DXR) Stock Fundamental Analysis

NASDAQ:DXR • US2394671034

12.0201 USD
-0.19 (-1.56%)
Last: Feb 24, 2026, 10:04 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, DXR scores 3 out of 10 in our fundamental rating. DXR was compared to 185 industry peers in the Health Care Equipment & Supplies industry. While DXR seems to be doing ok healthwise, there are quite some concerns on its profitability. DXR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year DXR was profitable.
  • In the past year DXR had a positive cash flow from operations.
  • Of the past 5 years DXR 4 years were profitable.
  • In the past 5 years DXR reported 4 times negative operating cash flow.
DXR Yearly Net Income VS EBIT VS OCF VS FCFDXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

1.2 Ratios

  • DXR has a Return On Assets of 5.01%. This is amongst the best in the industry. DXR outperforms 81.62% of its industry peers.
  • DXR has a Return On Equity of 5.05%. This is in the better half of the industry: DXR outperforms 77.30% of its industry peers.
Industry RankSector Rank
ROA 5.01%
ROE 5.05%
ROIC N/A
ROA(3y)6.45%
ROA(5y)5.61%
ROE(3y)6.73%
ROE(5y)6.34%
ROIC(3y)N/A
ROIC(5y)N/A
DXR Yearly ROA, ROE, ROICDXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • DXR has a Profit Margin of 2707.08%. This is amongst the best in the industry. DXR outperforms 100.00% of its industry peers.
  • DXR's Profit Margin has declined in the last couple of years.
  • DXR does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 2707.08%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-35.84%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DXR Yearly Profit, Operating, Gross MarginsDXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • DXR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, DXR has more shares outstanding
  • The debt/assets ratio for DXR has been reduced compared to a year ago.
DXR Yearly Shares OutstandingDXR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
DXR Yearly Total Debt VS Total AssetsDXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • An Altman-Z score of 157.63 indicates that DXR is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of DXR (157.63) is better than 100.00% of its industry peers.
  • DXR has a debt to FCF ratio of 0.19. This is a very positive value and a sign of high solvency as it would only need 0.19 years to pay back of all of its debts.
  • DXR has a Debt to FCF ratio of 0.19. This is amongst the best in the industry. DXR outperforms 92.43% of its industry peers.
  • DXR has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • DXR has a Debt to Equity ratio of 0.01. This is in the better half of the industry: DXR outperforms 72.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.19
Altman-Z 157.63
ROIC/WACCN/A
WACCN/A
DXR Yearly LT Debt VS Equity VS FCFDXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • DXR has a Current Ratio of 0.04. This is a bad value and indicates that DXR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DXR has a Current ratio of 0.04. This is amonst the worse of the industry: DXR underperforms 96.76% of its industry peers.
  • DXR has a Quick Ratio of 0.04. This is a bad value and indicates that DXR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.04, DXR is not doing good in the industry: 96.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
DXR Yearly Current Assets VS Current LiabilitesDXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • DXR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.53%, which is quite impressive.
  • DXR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -54.84% yearly.
  • Looking at the last year, DXR shows a very negative growth in Revenue. The Revenue has decreased by -56.97% in the last year.
  • DXR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -20.63% yearly.
EPS 1Y (TTM)22.53%
EPS 3Y-54.84%
EPS 5YN/A
EPS Q2Q%77.93%
Revenue 1Y (TTM)-56.97%
Revenue growth 3Y-24.67%
Revenue growth 5Y-20.63%
Sales Q2Q%-74.37%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • DXR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 902.04% yearly.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5806.43%
Revenue Next 2Y902.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DXR Yearly Revenue VS EstimatesDXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
DXR Yearly EPS VS EstimatesDXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.02 0.04 0.06 0.08

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 29.32, which means the current valuation is very expensive for DXR.
  • Compared to the rest of the industry, the Price/Earnings ratio of DXR indicates a somewhat cheap valuation: DXR is cheaper than 74.59% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of DXR to the average of the S&P500 Index (26.64), we can say DXR is valued inline with the index average.
Industry RankSector Rank
PE 29.32
Fwd PE N/A
DXR Price Earnings VS Forward Price EarningsDXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, DXR is valued a bit cheaper than the industry average as 73.51% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 50.54
EV/EBITDA N/A
DXR Per share dataDXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for DXR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DAXOR CORP

NASDAQ:DXR (2/24/2026, 10:04:16 AM)

12.0201

-0.19 (-1.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)03-04
Inst Owners1.73%
Inst Owner Change14.28%
Ins Owners5.89%
Ins Owner Change0.41%
Market Cap70.08M
Revenue(TTM)66.40K
Net Income(TTM)1.80M
Analysts80
Price Target23.97 (99.42%)
Short Float %0.23%
Short Ratio1.29
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 29.32
Fwd PE N/A
P/S 1055.38
P/FCF 50.54
P/OCF 50.54
P/B 1.97
P/tB 1.97
EV/EBITDA N/A
EPS(TTM)0.41
EY3.41%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.24
FCFY1.98%
OCF(TTM)0.24
OCFY1.98%
SpS0.01
BVpS6.11
TBVpS6.11
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.51
Profitability
Industry RankSector Rank
ROA 5.01%
ROE 5.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2707.08%
GM N/A
FCFM 2088.4%
ROA(3y)6.45%
ROA(5y)5.61%
ROE(3y)6.73%
ROE(5y)6.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-35.84%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.19
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 77.15%
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z 157.63
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.53%
EPS 3Y-54.84%
EPS 5YN/A
EPS Q2Q%77.93%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-56.97%
Revenue growth 3Y-24.67%
Revenue growth 5Y-20.63%
Sales Q2Q%-74.37%
Revenue Next Year5806.43%
Revenue Next 2Y902.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-83.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y144.02%
FCF growth 3YN/A
FCF growth 5Y-61.68%
OCF growth 1Y144.02%
OCF growth 3YN/A
OCF growth 5Y-61.68%

DAXOR CORP / DXR FAQ

Can you provide the ChartMill fundamental rating for DAXOR CORP?

ChartMill assigns a fundamental rating of 3 / 10 to DXR.


Can you provide the valuation status for DAXOR CORP?

ChartMill assigns a valuation rating of 2 / 10 to DAXOR CORP (DXR). This can be considered as Overvalued.


Can you provide the profitability details for DAXOR CORP?

DAXOR CORP (DXR) has a profitability rating of 3 / 10.


How financially healthy is DAXOR CORP?

The financial health rating of DAXOR CORP (DXR) is 5 / 10.


Can you provide the dividend sustainability for DXR stock?

The dividend rating of DAXOR CORP (DXR) is 0 / 10 and the dividend payout ratio is 0%.